• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Innate Pharma S.A. - American Depositary Shares (NQ:IPHA)

    2.490 +0.340 (+15.81%)
    Streaming Delayed Price Updated: 12:45 PM EDT, Aug 12, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 349,056
    Open 2.500
    Bid (Size) 2.480 (100)
    Ask (Size) 2.500 (700)
    Prev. Close 2.150
    Today's Range 2.441 - 2.640
    52wk Range 1.170 - 2.620
    Shares Outstanding 78,986,490
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    The trading volume of these stocks is deviating from the norm in today's session. ↗
    Via Chartmill
    News headline image
    Innate Pharma to Advance Lacutamab Towards Phase 3 Following Partnership With Sobi and Appoints New Chief Medical Officer
    From Innate Pharma SA
    Via Business Wire

    Performance

    YTD
    +36.8%
    +36.8%
    1 Month
    +39.1%
    +39.1%
    3 Month
    +83.1%
    +83.1%
    6 Month
    +40.3%
    +40.3%
    1 Year
    +15.3%
    +15.3%

    More News

    Read More
    News headline image
    Innate Pharma Enters Strategic Partnership With Sobi to License Lacutamab in T-cell Lymphoma
    From Innate Pharma SA
    Via Business Wire
    News headline image
    Innate Pharma to Participate in a Bladder Cancer Panel at the BTIG Virtual Biotechnology Conference
    From Innate Pharma SA
    Via Business Wire
    News headline image
    Innate Pharma Announces Completion of Enrollment in Phase 1 Dose Escalation Study of IPH4502, a Novel Nectin-4 Exatecan Antibody-drug Conjugate (ADC)
    From Innate Pharma SA
    Via Business Wire
    News headline image
    Outcome of Innate Pharma’s 2026 Annual General Meeting
    From Innate Pharma SA
    Via Business Wire
    News headline image
    Innate Pharma to participate in the Jefferies Global Healthcare Conference
    From Innate Pharma SA
    Via Business Wire
    News headline image
    Innate Pharma Q1 Earnings Call Highlights ↗
    Via MarketBeat
    Topics Earnings
    News headline image
    Innate Pharma Reports First Quarter 2026 Business Update and Financial Results
    From Innate Pharma SA
    Via Business Wire
    News headline image
    Number of Shares and Voting Rights of Innate Pharma as of April 16, 2026
    From Innate Pharma SA
    Via Business Wire
    News headline image
    Innate Pharma Announces Conference Call and Webcast for Q1 2026 Business Update
    From Innate Pharma SA
    Via Business Wire
    News headline image
    Innate Pharma to Participate in the D. Boral Capital Global Conference
    From Innate Pharma SA
    Via Business Wire
    News headline image
    Innate Pharma to Present MATISSE Phase 2 Interim Results of IPH5201 in Clinical Trials Plenary Session at AACR 2026
    From Innate Pharma SA
    Via Business Wire
    News headline image
    Innate Pharma to Hold Its Annual General Meeting of Shareholders on May 21, 2026
    From Innate Pharma SA
    Via Business Wire
    News headline image
    Number of Shares and Voting Rights of Innate Pharma as of April 9, 2026
    From Innate Pharma SA
    Via Business Wire
    News headline image
    Innate Pharma to Present at the AACR 2026 Oncology Industry Partnering Event
    From Innate Pharma SA
    Via Business Wire
    News headline image
    Innate Pharma to Participate in the Kempen Life Sciences Conference
    From Innate Pharma SA
    Via Business Wire
    News headline image
    Innate Pharma Files Its 2025 Universal Registration Document (Document D’enregistrement Universel) and 2025 Form 20-f Annual Report
    From Innate Pharma SA
    Via Business Wire
    News headline image
    Innate Pharma Reports Full Year 2025 Financial Results and Business Update
    From Innate Pharma SA
    Via Business Wire
    News headline image
    Innate Pharma Announces Conference Call and Webcast for Full Year 2025 Financial Results
    From Innate Pharma SA
    Via Business Wire
    News headline image
    Number of Shares and Voting Rights of Innate Pharma as of February 19, 2026
    From Innate Pharma SA
    Via Business Wire
    News headline image
    Innate Pharma to Participate in the Leerink Partners Global Healthcare Conference
    From Innate Pharma SA
    Via Business Wire
    News headline image
    Number of Shares and Voting Rights of Innate Pharma as of December 18, 2025
    From Innate Pharma SA
    Via Business Wire
    News headline image
    Innate Pharma Releases Its 2026 Financial Calendar
    From Innate Pharma SA
    Via Business Wire
    News headline image
    Number of Shares and Voting Rights of Innate Pharma as of November 27, 2025
    From Innate Pharma SA
    Via Business Wire

    Frequently Asked Questions

    Is Innate Pharma S.A. - American Depositary Shares publicly traded?
    Yes, Innate Pharma S.A. - American Depositary Shares is publicly traded.
    What exchange does Innate Pharma S.A. - American Depositary Shares trade on?
    Innate Pharma S.A. - American Depositary Shares trades on the Nasdaq Stock Market
    What is the ticker symbol for Innate Pharma S.A. - American Depositary Shares?
    The ticker symbol for Innate Pharma S.A. - American Depositary Shares is IPHA on the Nasdaq Stock Market
    What is the current price of Innate Pharma S.A. - American Depositary Shares?
    The current price of Innate Pharma S.A. - American Depositary Shares is 2.490
    When was Innate Pharma S.A. - American Depositary Shares last traded?
    The last trade of Innate Pharma S.A. - American Depositary Shares was at 08/12/26 12:45 PM ET
    What is the market capitalization of Innate Pharma S.A. - American Depositary Shares?
    The market capitalization of Innate Pharma S.A. - American Depositary Shares is 196.68M
    How many shares of Innate Pharma S.A. - American Depositary Shares are outstanding?
    Innate Pharma S.A. - American Depositary Shares has 197M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.